Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response.
Dragomir MP, Fuentes-Mattei E, Winkle M, Okubo K, Bayraktar R, Knutsen E, Qdaisat A, Chen M, Li Y, Shimizu M, Pang L, Liu K, Liu X, Anfossi S, Zhang H, Koch I, Tran AM, Mohapatra S, Ton A, Kaplan M, Anderson MW, Rothfuss SJ, Silasi R, Keshari RS, Ferracin M, Ivan C, Rodriguez-Aguayo C, Lopez-Berestein G, Georgescu C, Banerjee PP, Basar R, Li Z, Horst D, Vasilescu C, Bertilaccio MTS, Rezvani K, Lupu F, Yeung SC, Calin GA. Dragomir MP, et al. J Clin Invest. 2023 Jul 17;133(14):e158348. doi: 10.1172/JCI158348. J Clin Invest. 2023. PMID: 37261908 Free PMC article.
Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat B. Bayraktar R, et al. Among authors: lopez berestein g. Oncotarget. 2023 Oct 31;14:908-909. doi: 10.18632/oncotarget.28533. Oncotarget. 2023. PMID: 37921671 Free PMC article. No abstract available.
Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer.
Rodriguez-Aguayo C, Del C Monroig P, Redis RS, Bayraktar E, Almeida MI, Ivan C, Fuentes-Mattei E, Rashed MH, Chavez-Reyes A, Ozpolat B, Mitra R, Sood AK, Calin GA, Lopez-Berestein G. Rodriguez-Aguayo C, et al. Among authors: lopez berestein g. Cell Discov. 2023 Nov 8;9(1):111. doi: 10.1038/s41421-023-00611-6. Cell Discov. 2023. PMID: 37940695 Free PMC article. No abstract available.
Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy.
Corvigno S, Liu Y, Bayraktar E, Stur E, Bayram NN, Ahumada AL, Nagaraju S, Rodriguez-Aguayo C, Chen H, Vu TC, Wen Y, Liang H, Zhao L, Lee S, Lopez-Berestein G, Sood AK. Corvigno S, et al. Among authors: lopez berestein g. NPJ Precis Oncol. 2024 Apr 6;8(1):86. doi: 10.1038/s41698-024-00556-3. NPJ Precis Oncol. 2024. PMID: 38582949 Free PMC article.
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
LaFargue CJ, Amero P, Noh K, Mangala LS, Wen Y, Bayraktar E, Umamaheswaran S, Stur E, Dasari SK, Ivan C, Pradeep S, Yoo W, Lu C, Jennings NB, Vathipadiekal V, Hu W, Chelariu-Raicu A, Ku Z, Deng H, Xiong W, Choi HJ, Hu M, Kiyama T, Mao CA, Ali-Fehmi R, Birrer MJ, Liu J, Zhang N, Lopez-Berestein G, de Franciscis V, An Z, Sood AK. LaFargue CJ, et al. Nat Commun. 2023 Apr 26;14(1):2407. doi: 10.1038/s41467-023-36910-5. Nat Commun. 2023. PMID: 37100807 Free PMC article.
426 results